IANCU BRADEAN: Open Payments
NPI 1396520763 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $435 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $381 |
| Lundbeck LLC | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
Products named: REXULTI, ABILIFY ASIMTUFII, CAPLYTA, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across IL — which companies pay providers there.
